BriaCell Files Provisional Patent Application for Novel Treatment and Diagnosis of Coronavirus Disease

    NEXT STORY
    Mateon is Selected by IBM Watson Health for the Use of IBM Clinical Development Solution at No Cost for Phase II Clinical Trial of OT-101 for COVID-19
    PREV STORY
    Global medical supplies market to record 13.5% CAGR through 2026
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    BioXcel Therapeutics Announces BXCL501 Met the Primary and All Secondary Endpoints in the TRANQUILITY Phase 1b/2 Study for the Acute Treatment of Agitation in Dementia, including Alzheimer’s Disease

    author_avatar
    NASDAQ Market News

    Molecular Diagnostics Devices And Equipment Market Faces Great Demand Due To Increased Testing During The COVID-19 Pandemic

    author_avatar
    NASDAQ Market News

    Pluristem Therapeutics Recaps Key Opinion Leader Call Reviewing Hematological Programs

    author_avatar
    NASDAQ Market News